Perrigo plans to separate prescription pharma business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- Wall St set for muted open as tech stocks take a breather
- Stifel sees AI supply constraints ahead of Q3 tech earnings
- Schneider Electric to buy US software firm PTC in $22.6 billion deal
Mylan N.V. (MYL) Announces U.S. Launch of Tadalafil Tablets USP 20mg, First Generic for Eli Lilly's (LLY) Adcirca Tablets
August 13, 2018 11:06 AM EDTGlobal pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first generic version of the reference listed drug, Eli Lilly and... More
Cantor Fitzgerald Remains Bullish on Perrigo (PRGO) Despite Guidance Cut
August 9, 2018 11:22 AM EDTCantor Fitzgerald analsyt Louise Chen remains positive on Perrigo Co. (NYSE: PRGO) despite lowered FY18 guidance.
Chen notes weakness was driven by headwinds in its Rx business, which it now expects to sell, merge or separate out in 2H19.... More



